Clinical Trial Update: A Clinical Study Assessing the Efficacy of Chidamide for CD30-positive Peripheral T-cell Lymphoma (PTCL). [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the efficacy of chidamide for CD30-positive peripheral T-cell lymphoma. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Peripheral T Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING